ERIS Lifesciences Ltd Nine Monthly Results

Gross Sales

2,176.66

1,444.03

1,265.22

1,025.07

918.39

Excise Duty

0

0

0

0

0

Net Sales

2,176.66

1,444.03

1,265.22

1,025.07

918.39

Other Operating Income

11.68

14.19

17.13

16.03

15.27

Other Income

10.41

8.67

10.15

18.03

6.5

Total Income

2,198.75

1,466.89

1,292.5

1,059.13

940.15

Total Expenditure

1,423.53

931.82

864.5

653.04

597.6

PBIDT

775.22

535.07

428

406.09

342.55

Interest

177.01

51.77

17.3

2.89

1.26

PBDT

598.21

483.3

410.7

403.2

341.3

Depreciation

237.62

128.7

81.96

46.34

31.53

Minority Interest Before NP

0

0

0

0

0

Tax

80.45

66.49

57.66

74.45

56.36

Deferred Tax

7.44

-29.32

-41.6

-43.41

-33.48

Reported Profit After Tax

272.7

317.43

312.68

325.82

286.89

Minority Interest After NP

14.31

-3.59

-4.06

0

0

Net Profit after Minority Interest

258.39

321.02

316.74

325.82

286.89

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

258.39

321.02

316.74

325.82

286.89

EPS (Unit Curr.)

18.99

23.6

23.29

23.98

21.13

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

735

0

0

0

0

Equity

13.61

13.6

13.6

13.59

13.58

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

35.61

37.05

33.82

39.61

37.29

PBDTM(%)

27.48

33.46

32.46

39.33

37.16

PATM(%)

12.52

21.98

24.71

31.78

31.23